Human P301L-mutant tau expression in mouse entorhinal-hippocampal network causes tau aggregation and presynaptic pathology but no cognitive deficits.
Accumulation of hyperphosphorylated tau in the entorhinal cortex (EC) is one of the earliest pathological hallmarks in patients with Alzheimer's disease (AD). It can occur before significant Aβ deposition and appears to "spread" into anatomically connected brain regions. To determine...
Main Authors: | Julie A Harris, Akihiko Koyama, Sumihiro Maeda, Kaitlyn Ho, Nino Devidze, Dena B Dubal, Gui-Qiu Yu, Eliezer Masliah, Lennart Mucke |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3454317?pdf=render |
Similar Items
-
Tau reduction does not prevent motor deficits in two mouse models of Parkinson's disease.
by: Meaghan Morris, et al.
Published: (2011-01-01) -
Tau and amyloid-related pathologies in the entorhinal cortex have divergent effects in the hippocampal circuit
by: S.L. Angulo, et al.
Published: (2017-12-01) -
Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice.
by: Sefika Ozcelik, et al.
Published: (2013-01-01) -
Biochemical distribution of tau protein in synaptosomal fraction of transgenic mice expressing human P301L tau
by: Naruhiko eSahara, et al.
Published: (2014-03-01) -
Development of P301S tau seeded organotypic hippocampal slice cultures to study potential therapeutics
by: James M. McCarthy, et al.
Published: (2021-05-01)